Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11222501rdf:typepubmed:Citationlld:pubmed
pubmed-article:11222501lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0019629lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0024518lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C1368327lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:11222501lifeskim:mentionsumls-concept:C0443177lld:lifeskim
pubmed-article:11222501pubmed:issue3lld:pubmed
pubmed-article:11222501pubmed:dateCreated2001-3-6lld:pubmed
pubmed-article:11222501pubmed:abstractTextThe CD94/NKG2A heterodimer is an inhibitory receptor expressed on a subset of mouse NK cells. CD94/NKG2A recognizes the non-classical MHC class I (class Ib) molecule Qa-1(b) and inhibits NK cytotoxicity. Qa-1(b) presents a peptide derived from the leader sequence of classical MHC class I molecules. Here, we examined the role of CD94/NKG2A in T cell-mediated cytotoxicity. Soluble tetrameric Qa-1(b) bound to almost all CD8(+), but not CD4(+), T cells. This binding seems to be mediated by CD8, because COS cells transfected with CD8 also bound Qa-1(b) tetramer. Therefore, the expression of CD94/NKG2 in T cells was further examined by single-cell RT-PCR. Most murine CD8(+) T cells constitutively expressed CD94 and NKG2A transcripts, whereas they were not detected in CD4(+) T cells. Co-expression of Qa-1(b) and D(k) on target cells significantly inhibited cytotoxicity of D(k)-specific cytotoxic T lymphocytes generated by mixed lymphocyte reaction, indicating that Qa-1(b) on antigen-presenting cells interacts with CD94/NKG2A on CD8 T cells and regulates classical MHC class I-restricted cytotoxic T cells. These results suggest a significant role of CD94/NKG2A as an inhibitory receptor on CD8(+) T cells.lld:pubmed
pubmed-article:11222501pubmed:languageenglld:pubmed
pubmed-article:11222501pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:citationSubsetIMlld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11222501pubmed:statusMEDLINElld:pubmed
pubmed-article:11222501pubmed:monthMarlld:pubmed
pubmed-article:11222501pubmed:issn0953-8178lld:pubmed
pubmed-article:11222501pubmed:authorpubmed-author:KubotaAAlld:pubmed
pubmed-article:11222501pubmed:authorpubmed-author:TakeiFFlld:pubmed
pubmed-article:11222501pubmed:authorpubmed-author:SalcedoMMlld:pubmed
pubmed-article:11222501pubmed:authorpubmed-author:LevyD HDHlld:pubmed
pubmed-article:11222501pubmed:authorpubmed-author:LohwasserSSlld:pubmed
pubmed-article:11222501pubmed:issnTypePrintlld:pubmed
pubmed-article:11222501pubmed:volume13lld:pubmed
pubmed-article:11222501pubmed:ownerNLMlld:pubmed
pubmed-article:11222501pubmed:authorsCompleteYlld:pubmed
pubmed-article:11222501pubmed:pagination321-7lld:pubmed
pubmed-article:11222501pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:meshHeadingpubmed-meshheading:11222501...lld:pubmed
pubmed-article:11222501pubmed:year2001lld:pubmed
pubmed-article:11222501pubmed:articleTitleThe non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.lld:pubmed
pubmed-article:11222501pubmed:affiliationTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC V5Z 1L3 Canada.lld:pubmed
pubmed-article:11222501pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11222501pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11222501pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11222501lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11222501lld:pubmed